Observational Study With Everolimus (Certican) in Combination With Low-dose Cyclosporine in De Novo Heart Transplant Recipients

详细信息    查看全文

• 作者：Hans B. Lehmkuhl ; Daniel Mai ; Michael D ; el ; Christoph Knosalla ; Nicola E. Hiemann ; Onnen Grauhan ; Michael Huebler ; Miralem Pasic ; Yuguo Weng ; Rudolph Meyer ; Markus Rothenburger ; Manfred Hummel ; Rol
• 关键词：Medical malpractice ; Insurance ; Litigation
• 刊名：The Journal of Heart and Lung Transplantation
• 出版年：2007
• 出版时间：July 2007
• 年：2007
• 卷：26
• 期：7
• 页码：700-704
• 全文大小：197 K

文摘

We test for effects of tort liability on the use of certain diagnostic procedures, where the health care providers’ expected cost of litigation is proxied by the risk-sharing arrangements agreed with their insurers. 2SLS and GMM estimators are adopted to test for possible endogeneity of these risk-sharing arrangements. Our findings are consistent with the exercise of liability-induced discretion by hospitals, especially regarding use of costly diagnostic imaging procedures. Hospitals facing higher expected costs per claim as a consequence of higher deductibles used these tests more frequently, after controlling for activity levels and casemix. These results are consistent with hospitals reacting to the incentives provided by a clinical negligence compensation system.